Company Overview and News

109
Singapore pledges to cut cash, cheques on path to digital economy

2018-06-21 malaymail
SINGAPORE, June 21 — Singapore is accelerating the shift toward digital payments by pledging to eliminate cheque usage by 2025 and slash cash withdrawals from automated telling machines.
STAN C.WSA MLYNF HSB C.WS.B D05 DBSDF STAB C.WS.A STAC SCBFF STAN C.PRP C.PRU HSBC.PRA HSBC HBCYF C.PRS HCS.PRB UOVEF DBSDY MLYBY C C.PRL C.PRJ C.PRK C.PRG HCS O39 U11 C.PRC 0005 1155 C.PRPCL CGBBW 580001 UOVEY 2888 HSEA HSEB

143
Walmart Kicks Off Mega Bond Deal to Fund Flipkart Purchase - Bloomberg

2018-06-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
WFCNP BCS.PRD BCS BCS.PRC C.WSA BCS.PRA WFC.PRL WFC.PRJ HSB WFC.PRT 83SF C.WS.B WFC.PRR WFC.PRQ 83SK WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP MON C.PRU WFC.PRY HSBC.PRA WFC.PRX HSBC WFC.PRW WFC.PRV HBCYF 47MC C.PRS WFC WFC.WS HCS.PRB C.PRL C C.PRJ C.PRK C.PRG HCS C.PRC 0005 BCS.PR C.PRPCL CGBBW HSEA HSEB

143
Walmart kickstarts mega fundraising to finance Flipkart deal

2018-06-20 livemint
New York: Walmart Inc. is selling bonds to help finance its acquisition in India’s biggest e-commerce firm Flipkart, stuffing the US investment grade market with another jumbo deal just two days after the second-largest of the year.
WFCNP BCS.PRD BCS BCS.PRC C.WSA BCS.PRA WFC.PRL WFC.PRJ HSB WFC.PRT 83SF C.WS.B WFC.PRR WFC.PRQ 83SK WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP MON C.PRU WFC.PRY HSBC.PRA WFC.PRX HSBC WFC.PRW WFC.PRV HBCYF 47MC C.PRS WFC WFC.WS HCS.PRB C.PRL C C.PRJ C.PRK C.PRG HCS C.PRC 0005 BCS.PR C.PRPCL CGBBW HSEA HSEB

0
HBCYF / HSBC Holdings Plc 424B5 (Prospectus)

2018-06-19 sec.gov
424B5 Table of Contents CALCULATION OF REGISTRATION FEE
HBCYF

0
HBCYF / HSBC Holdings Plc 8-A12B

2018-06-19 sec.gov
8-A12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
HBCYF

0
HBCYF / HSBC Holdings Plc FORM 6-K (Current Report of Foreign Issuer)

2018-06-19 sec.gov
Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
HBCYF

0
HBCYF / HSBC Holdings Plc FWP

2018-06-15 sec.gov
FWP Filed pursuant to Rule 433 Registration No. 333-223191 June 15, 2018 HSBC Holdings plc £1,000,000,000 2.
HBCYF

0
HBCYF / HSBC Holdings Plc 424B2 (Prospectus)

2018-06-15 sec.gov
424B2 Table of Contents Filed Pursuant to Rule 424(b)(2) Registration No. 333-223191 The information in this preliminary prospectus supplement is incomplete and may be changed. This preliminary prospectus supplement and the accompanying prospectus is not an offer to sell these securities and it
HBCYF

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

CUSIP: G4634U169